Briacell Therapeutics Corp. T.BCT

Alternate Symbol(s): BCTX | BCTXW

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops immunotherapies to transform cancer care. The Company’s lead drug candidate, Bria-IMT, is a cell-based patented immunotherapy that stimulates a patient’s own cancer fighting cells to attack and destroy breast cancer tumors. The Company is advancing its targeted immunotherapy program by prioritizing a Phase II clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor. The Company is focused on conducting a Phase I/IIa clinical trial of Bria-IMT in a combination study with Incyte’s immune PD-1 inhibitor, retifanlimab, in advanced breast cancer. The Company is also developing Bria-OTS, an off-the-shelf personalized approach to whole cell cancer immunotherapy. The Bria-OTS immunotherapy is based on a patient’s HLA-type. Its pipeline also includes Bria-Pros, Bria-Lung, Bria-Mel and sCD80, which are in development to treat various cancers.

TSX:BCT - Post by User

Briacell Therapeutics Corp. > Running out of cash?

<< Previous

Bullboard Posts

Next >>

Comment by Unicorn9000on Dec 30, 2023 4:18am

87 Views

Post# 35804950

RE:RE:Running out of cash?

MrDales62 wrote: If todays news is that good, someone will come knocking.

GLTA

Looks like someone already has.
it has been going up the last few trading days with big sp moves.

it could be 15 to 20 in a flash with this low float.

let's go

<< Previous

Bullboard Posts

Next >>

Bombardier reveals NetJets as buyer behind US$6 billion order